Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

NCT02165397 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Waldenström's Macroglobulinemia

Interventions

DRUG: Ibrutinib
DRUG: Placebo
DRUG: Rituximab

Sponsor

Pharmacyclics LLC.

Collaborators

[object Object]